Since pharmacological activation of DRD2 ameliorates insulin resistance, in various obese animal models [17, 30], we hypothesized that modulation of DRD2-mediated neurotransmission could reverse the metabolic phenotypes of DIO and DR mice. The gene discussed is DRD2; the disease is Insulin resistance.